Replies to post #568 on PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[genisi]

Shire said they have about 500 patients on Vpriv but majority are not paying yet but in time, maybe even as soon as Q2 we'll see a boost in sales. Btw, they also said Replagal has added about 400 patients during the last two quarters.

[genisi]

Judging by Genzyme's Cerezyme plunge I imagine the number will really shoot up in Q2.

Shire booked sales of $28.7M for Vpriv (velaglucerase for Gaucher) in Q2.